I bought CTIX at .79 in 2011. It promptly dropped to .35
I bought CTIX at .79 in 2011. It promptly dropped to .35 (and then worse, but I stopped watching when it did that). About a year later I noticed that it had started moving again, and started buying again.
Now, what did CTIX have 6 years ago when it was at .79? It had NO drugs in clinical trials. It was developing Prurisol and Kevetrin. It had not yet bought the Brilacidin intellectual property from the PolyMedix bankruptcy.
And yet, it was priced at only 20 cents less than the current price. What do we have now?
Prurisol, Kevetrin, and multiple formulations of Brilacidin for different diseases, all in clinical trials. All of these trials have been successful to date.
So when people claim that share price is low because of something the company is supposedly doing wrong, think about this. Let's say that CTIX was priced appropriately at .35 6 years ago, rather than the .79 I paid.
Do you think that having 50% more intellectual property (with the addition of Brilacidin), and half a dozen successful clinical trials continuing to progress would make the company worth a mere 3 times its price of 6 years ago? Or do you think that this shows that this is not efficient market pricing, and that the stock is worth far more? And, as a corollary, that there must be some other market force that is depressing the price, like a hedge fund that collaborates with negative, untrue articles to depress the stock price?
4
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
ACR Poker's High Stakes Launch with $20M Series In the world of online poker, where fortunes are won and lost faster than you can say 'all in,' ACR Poker has just dealt a monumental hand. On November 8th, they kicked off their Online Super Series (OSS) with a staggering $20 million guarantee that's got every poker aficionado buzzing. Not to mention, they crowned their...
Continue Reading
A Taste of Taiwan in Ghana The whisky world just got a bit smaller with Kavalan’s latest move If you know whisky, you know Kavalan, the Taiwanese gem that's been steadily building its global footprint. And now, they've set their sights on Ghana. Yup, this one's not about rattling sabers but raising glasses! Partnering with Say Cheers Limited, Kavalan enters Ghana,...
Continue Reading
A Bright Idea Shines with Solar Cooking Some days, you stumble across an idea that just seems destined to shake things up, and COOK SOL SOLAR POWER COOKER might just be one of those spark plugs ready to ignite the world of outdoor cooking. Invented by a plucky thinker from Florence, South Carolina, this little gadget isn't just about frying up eggs on a camping trip. Nah,...
Continue Reading
A Patch to Simplify Mealtime Insulin So, it turns out CeQur is stepping up to the plate with their new wearable insulin patch called CeQur Simplicity. They just rolled it out nationally, and it's not your grandmother's insulin delivery method—this one sticks around for a whole week with some nifty up-to-1-unit dosing. If you're shoving insulin needles or pens into your...
Continue Reading
You're Not Just a Number Here Amid the usual buzzwords in the corporate world, Cherokee Federal has managed to turn some heads with a pretty impressive nod from Military Times. If you've been around the block, you know these lists can feel like a marketing gimmick, but this one—to their credit—comes with some genuine weight. Cherokee Federal moved up 27 slots,...
Continue Reading
Engineering a Leap in Prenatal Care Talk about flipping the script on prenatal diagnostics. A team from Florida International University (FIU) thinks they've got just the thing to spot early risks of preterm births with a device called PPRIM. It's the brainchild of some sharp minds, including FIU doctoral students Jenny Pei and Amanda Sanchez, and it's come out of FIU's...
Continue Reading
Kicking Off a New Chapter in Workforce Management Well, when a global workforce giant teams up with a football powerhouse like Atlético de Madrid, it sure does mark a significant play on the field of employment strategies. Safeguard Global has just inked a multi-year partnership with Atlético, signing on as their Official Workforce Partner in Spain. It's not every day...
Continue Reading
The Unrivaled Appeal of EICMA 2026 Let me paint you a picture: over 600,000 folks hustling and bustling through the colossal halls of EICMA 2026, each one eager to feast their eyes on the newest feats of two-wheeled marvels. This gathering was no small potatoes. We're talking a 6% uptick in mere foot traffic alone compared to last year, not to mention an impressive spike...
Continue Reading
Forget Recognition—It's All About Relevance Now Brand hearts are breaking, folks. That classic suite of household names just took a body blow from the Consequential Brand™ Test. Out of 73, a single champ emerged. Why? Because in the age where AI drives recommendations, it turns out recognizability ain't cutting it. This ain't your granddad’s customer loyalty game...
Continue Reading
Community Safety Takes Center Stage When it comes to community safety, the urgency can't be overstated, especially in a place like Lower Salford Township, Pennsylvania. This small township with around 16,000 residents has managed to pull off quite the feat in enhancing its emergency response capabilities by deploying 16 Avive Connect AED® devices throughout its police...
Continue Reading
Top 5 Most Recently Viewed Articles
Transforming Access to Capital in Trading In the competitive landscape of trading, both professional and independent traders are realizing that success is no longer just about having the best strategies. Instead, the focus is shifting towards scalable capital infrastructure, a crucial element that can enhance one’s trading performance. Introducing QuickFund AI—a...
Continue Reading
NeurAxis Revolutionizes Treatment for Functional Dyspepsia NeurAxis, Inc. (NYSE American: NRXS), a pioneer in medical technology, has achieved a momentous milestone by securing FDA clearance for its innovative percutaneous electrical nerve field stimulation (PENFS) technology. This approval is specifically aimed at treating functional abdominal pain (FAP) associated with...
Continue Reading
Understanding the Recent Downgrade of Obic Co Ltd Recently, there has been some notable movement in the evaluation of Obic Co Ltd (4684:JP) (OTC: OBIIF) shares. Jefferies, a respected financial services company, has downgraded Obic's stock from a Buy rating to Hold. This revision comes amidst shifting market dynamics that have brought a renewed focus on domestic demand...
Continue Reading
Varonis to Report Third Quarter Results Soon Varonis Systems, Inc. (Nasdaq: VRNS), renowned for its innovative data security solutions, is preparing to announce its financial performance for the third quarter of 2024. Stakeholders and analysts alike are keenly awaiting this report, which will be released after the U.S. markets close, specifically on a Tuesday at the end...
Continue Reading
Advancements in Managed Services with AvePoint Elements AvePoint (NASDAQ: AVPT) is steering a monumental shift in the managed services landscape with the launch of its next-generation AvePoint Elements. This innovative solution promises to revamp client, cloud, and tenant management for managed service providers (MSPs) by harnessing the power of artificial intelligence,...
Continue Reading